1420 related articles for article (PubMed ID: 12875979)
21. Zinc-induced anti-apoptotic effects in SH-SY5Y neuroblastoma cells via the extracellular signal-regulated kinase 1/2.
An WL; Pei JJ; Nishimura T; Winblad B; Cowburn RF
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):40-7. PubMed ID: 15857667
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
23. mTor mediates tau localization and secretion: Implication for Alzheimer's disease.
Tang Z; Ioja E; Bereczki E; Hultenby K; Li C; Guan Z; Winblad B; Pei JJ
Biochim Biophys Acta; 2015 Jul; 1853(7):1646-57. PubMed ID: 25791428
[TBL] [Abstract][Full Text] [Related]
24. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y.
Pope WB; Lambert MP; Leypold B; Seupaul R; Sletten L; Krafft G; Klein WL
Exp Neurol; 1994 Apr; 126(2):185-94. PubMed ID: 7925819
[TBL] [Abstract][Full Text] [Related]
25. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.
Li X; Alafuzoff I; Soininen H; Winblad B; Pei JJ
FEBS J; 2005 Aug; 272(16):4211-20. PubMed ID: 16098202
[TBL] [Abstract][Full Text] [Related]
26. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.
Pei JJ; Braak E; Braak H; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
J Neuropathol Exp Neurol; 1999 Sep; 58(9):1010-9. PubMed ID: 10499443
[TBL] [Abstract][Full Text] [Related]
27. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase.
Lehman JA; Calvo V; Gomez-Cambronero J
J Biol Chem; 2003 Jul; 278(30):28130-8. PubMed ID: 12740386
[TBL] [Abstract][Full Text] [Related]
29. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
Su JH; Cummings BJ; Cotman CW
Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
[TBL] [Abstract][Full Text] [Related]
30. Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein.
Lekmine F; Sassano A; Uddin S; Smith J; Majchrzak B; Brachmann SM; Hay N; Fish EN; Platanias LC
Exp Cell Res; 2004 Apr; 295(1):173-82. PubMed ID: 15051500
[TBL] [Abstract][Full Text] [Related]
31. Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.
Tang Z; Bereczki E; Zhang H; Wang S; Li C; Ji X; Branca RM; Lehtiö J; Guan Z; Filipcik P; Xu S; Winblad B; Pei JJ
J Biol Chem; 2013 May; 288(22):15556-70. PubMed ID: 23585566
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
[TBL] [Abstract][Full Text] [Related]
33. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
[TBL] [Abstract][Full Text] [Related]
34. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Grundke-Iqbal I; Iqbal K; Bogdanovic N; Winblad B; Cowburn RF
Brain Res; 1998 Jun; 797(2):267-77. PubMed ID: 9666145
[TBL] [Abstract][Full Text] [Related]
35. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
36. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
Kondratick CM; Vandré DD
J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
[TBL] [Abstract][Full Text] [Related]
38. New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins.
Condamines O; Buée-Scherrer V; Boissier L; Wattez A; Delacourte A; Pau B; Mourton-Gilles C
Neurosci Lett; 1995 Jun; 192(2):81-4. PubMed ID: 7675326
[TBL] [Abstract][Full Text] [Related]
39. Neurofibrillary pathology and aluminum in Alzheimer's disease.
Shin RW; Lee VM; Trojanowski JQ
Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
[TBL] [Abstract][Full Text] [Related]
40. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
Keck S; Nitsch R; Grune T; Ullrich O
J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
